The dynamically emerging trend of decentralised sample prep and testing of biosamples such as blood, water and industrial fluids in the life sciences at the point-of-use spurred the emergence of a plethora of microfluidic technologies. Based on a thorough market analysis, this presentation will illustrate the approach of FPC@DCU - the Fraunhofer Project Centre for Embedded Bioanalytical Systems at Dublin City University - to accelerate and de-risk development of microfluidics-enabled solutions, mainly in the context of the life-science, towards high-technology-readiness levels (TRLs). In a platform-based design-for manufacture approach adopted from established industries, manifold applications can swiftly be derived from a single set of design rules, and quasi seamlessly be scaled-up from prototyping to pilot series and eventual mass production. This strategy will be explained along FPC@DCU's centrifugal microfluidic "Lab-on-a-Disc" platform which integrates and automates multiplexed multi-step / multi-reagent bioassay protocols in a robust, user-friendly and cost-efficient manner.